品牌 | 货号 | 包装单位 | 货期 | CAS | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|---|
阿拉丁 | D101549-20mg | 20mg | 现货 | 27200-12-0 |
二氢杨梅素 Dihydromyricetin |
分析标准品, ≥98% |
|
|
阿拉丁 | D299476-1g | 1g | 现货 | 27200-12-0 |
二氢杨梅素 Dihydromyricetin |
Moligand™, ≥97%(HPLC) |
|
|
阿拉丁 | D299476-250mg | 250mg | 现货 | 27200-12-0 |
二氢杨梅素 Dihydromyricetin |
Moligand™, ≥97%(HPLC) |
|
|
阿拉丁 | D299476-5g | 5g | 现货 | 27200-12-0 |
二氢杨梅素 Dihydromyricetin |
Moligand™, ≥97%(HPLC) |
|
|
阿拉丁 | D101549-50mg | 50mg | 现货 | 27200-12-0 |
二氢杨梅素 Dihydromyricetin |
分析标准品, ≥98% |
|
|
阿拉丁 | D101549-100mg | 100mg | 现货 | 27200-12-0 |
二氢杨梅素 Dihydromyricetin |
分析标准品, ≥98% |
|
|
阿拉丁 | D101549-1g | 1g | 现货 | 27200-12-0 |
二氢杨梅素 Dihydromyricetin |
分析标准品, ≥98% |
|
|
阿拉丁 | D101549-500mg | 500mg | 现货 | 27200-12-0 |
二氢杨梅素 Dihydromyricetin |
分析标准品, ≥98% |
|
|
阿拉丁 | D101549-5g | 5g | 期货,请咨询 | 27200-12-0 |
二氢杨梅素 Dihydromyricetin |
分析标准品, ≥98% |
|
|
阿拉丁 | D408827-1ml | 1ml | 现货 | 27200-12-0 |
二氢杨梅素 Dihydromyricetin |
10mM in DMSO |
|
|
阿拉丁 | D299476-100g | 100g | 现货 | 27200-12-0 |
二氢杨梅素 Dihydromyricetin |
Moligand™, ≥97%(HPLC) |
|
|
阿拉丁 | D299476-25g | 25g | 现货 | 27200-12-0 |
二氢杨梅素 Dihydromyricetin |
Moligand™, ≥97%(HPLC) |
|
|
梯希爱 | D5464-200MG | 200MG | 现货 | 27200-12-0 |
二氢杨梅素 Dihydromyricetin |
97.0% |
|
|
梯希爱 | D5464-1G | 1G | 现货 | 27200-12-0 |
二氢杨梅素 Dihydromyricetin |
97.0% |
|
|
毕得 | BD114231-10mg | 10mg | 现货 | 27200-12-0 |
(2R,3R)-3,5,7-三羟基-2-(3,4,5-三... (2R,3R)-3,5,7-Trihydroxy-2-(... |
98% |
|
|
毕得 | BD114231-100mg | 100mg | 现货 | 27200-12-0 |
(2R,3R)-3,5,7-三羟基-2-(3,4,5-三... (2R,3R)-3,5,7-Trihydroxy-2-(... |
98% |
|
|
毕得 | BD114231-1g | 1g | 现货 | 27200-12-0 |
(2R,3R)-3,5,7-三羟基-2-(3,4,5-三... (2R,3R)-3,5,7-Trihydroxy-2-(... |
98% |
|
|
毕得 | BD114231-5g | 5g | 现货 | 27200-12-0 |
(2R,3R)-3,5,7-三羟基-2-(3,4,5-三... (2R,3R)-3,5,7-Trihydroxy-2-(... |
98% |
|
|
毕得 | BD114231-10g | 10g | 现货 | 27200-12-0 |
(2R,3R)-3,5,7-三羟基-2-(3,4,5-三... (2R,3R)-3,5,7-Trihydroxy-2-(... |
98% |
|
|
毕得 | BD114231-25g | 25g | 现货 | 27200-12-0 |
(2R,3R)-3,5,7-三羟基-2-(3,4,5-三... (2R,3R)-3,5,7-Trihydroxy-2-(... |
98% |
|
|